Market Overview:
The global smart drug delivery solutions market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for minimally invasive and targeted drug delivery systems, rising prevalence of chronic diseases, and growing focus on personalized medicine. Based on type, the global smart drug delivery solutions market is segmented into injection, implanted, and others. The implantable segment is expected to grow at the highest CAGR during the forecast period owing to its advantages such as reduced dosage requirements and improved patient compliance rates. By application, hospitals are estimated to account for the largest share of the global smart drug delivery solutions market in 2018 followed by clinics. However, clinics are projected to register higher growth rates during the forecast period due to their growing popularity among patients for outpatient procedures.
Product Definition:
A drug delivery system that employs Smart technology for the efficient and targeted delivery of drugs to a specific area or organ in the body. The importance of Smart Drug Delivery Solutions is that it can improve the efficacy and safety of drugs by delivering them to the right place in the body, increasing their absorption into tissues, and reducing potential side effects.
Injection:
Injection is a smart drug delivery technology that enhances the capabilities of drugs by modifying their dynamics. It helps in maintaining the optimal dosage and reduces side effects by controlling release rates. In addition, it offers benefits such as dose accuracy, reduced fluctuation in plasma drug levels, improved patient compliance & satisfaction along with greater safety and efficacy compared to oral administration methods.
Implanted:
The global market for the use of implants in smart drug delivery solutions was valued at USD 3.6 billion in 2015 and is expected to grow at a CAGR of XX% over the forecast period. The increasing need for targeted drug delivery systems that help achieve better results with improved patient compliance is one of the key factors driving growth.
Application Insights:
Based on application, the market is segmented into hospitals, clinics and others. The hospitals segment dominated the global smart drug delivery solutions market in 2017 due to factors such as increasing prevalence of chronic diseases and growing aging population. Moreover, an increase in government funding for the development of advanced healthcare facilities is further expected to boost product demand over the forecast period.
The clinics segment is anticipated to witness substantial growth during the forecast period owing to factors such as technological advancements coupled with rising health consciousness among consumers globally. Increasing demand for minimally invasive surgeries has also driven this industry toward developing new products that are less invasive than traditional methods of medication or surgery. For instance, a company called AdnaGen has developed a non-invasive blood glucose monitoring device that can deliver insulin through skin patches without having to remove it every night before sleeping like other conventional devices do.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period. This can be attributed to increasing R&D investments by government and private entities, rising adoption of technologically advanced products, and high healthcare expenditure in this region. Moreover, growing demand for smart drugs that are effective substitutes for Adderall and other stimulants used to treat attention-deficit/hyperactivity disorder (ADHD) is driving growth in North America.
Asia Pacific is anticipated to witness significant growth over the forecast period owing to factors such as improving healthcare infrastructure; rising awareness about mental health issues; increased focus on drug discovery & development activities by pharmaceutical companies; supportive economic policies aimed at boosting medical tourism; and an increase in public & private funding for R&D activities related to new medicines development.
Growth Factors:
- Increasing demand for novel and targeted drug delivery solutions to improve patient outcomes.
- Growing prevalence of chronic diseases that require long-term treatment, such as cancer, diabetes, and heart disease.
- Rising number of approvals for novel drugs and biologics by the FDA and other regulatory agencies worldwide.
- Advances in nanotechnology and other drug delivery platforms that can improve the efficacy and safety of medications.
Scope Of The Report
Report Attributes
Report Details
Report Title
Smart Drug Delivery Solutions Market Research Report
By Type
Injection, Implanted, Others
By Application
Hospitals, Clinic, Others
By Companies
Merck, Amgen, Teva, Roche, Johnson & Johnson, TOLMAR, Union Chimique Belge, Celgene, Pfizer, Gilead Sciences, Sanofi, Takeda, Bausch&Lomb, Astellas, AMAG Pharmaceuticals, AbbVie, Dr Reddy
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
185
Number of Tables & Figures
130
Customization Available
Yes, the report can be customized as per your need.
Global Smart Drug Delivery Solutions Market Report Segments:
The global Smart Drug Delivery Solutions market is segmented on the basis of:
Types
Injection, Implanted, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinic, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Merck
- Amgen
- Teva
- Roche
- Johnson & Johnson
- TOLMAR
- Union Chimique Belge
- Celgene
- Pfizer
- Gilead Sciences
- Sanofi
- Takeda
- Bausch&Lomb
- Astellas
- AMAG Pharmaceuticals
- AbbVie
- Dr Reddy
Highlights of The Smart Drug Delivery Solutions Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Injection
- Implanted
- Others
- By Application:
- Hospitals
- Clinic
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Smart Drug Delivery Solutions Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Smart Drug Delivery Solutions is a company that provides drug delivery solutions to healthcare providers. Their products include devices and systems that help doctors and nurses administer medications more accurately and efficiently.
Some of the major companies in the smart drug delivery solutions market are Merck, Amgen, Teva, Roche, Johnson & Johnson, TOLMAR, Union Chimique Belge, Celgene, Pfizer, Gilead Sciences, Sanofi, Takeda, Bausch&Lomb, Astellas, AMAG Pharmaceuticals, AbbVie, Dr Reddy.
The smart drug delivery solutions market is expected to grow at a compound annual growth rate of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Smart Drug Delivery Solutions Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Smart Drug Delivery Solutions Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Smart Drug Delivery Solutions Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Smart Drug Delivery Solutions Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Smart Drug Delivery Solutions Market Size & Forecast, 2020-2028
4.5.1 Smart Drug Delivery Solutions Market Size and Y-o-Y Growth
4.5.2 Smart Drug Delivery Solutions Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Injection
5.2.2 Implanted
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinic
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Smart Drug Delivery Solutions Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Smart Drug Delivery Solutions Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Injection
9.6.2 Implanted
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinic
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Injection
10.6.2 Implanted
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinic
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Injection
11.6.2 Implanted
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinic
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Injection
12.6.2 Implanted
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinic
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Injection
13.6.2 Implanted
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinic
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Smart Drug Delivery Solutions Market: Competitive Dashboard
14.2 Global Smart Drug Delivery Solutions Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Merck
14.3.2 Amgen
14.3.3 Teva
14.3.4 Roche
14.3.5 Johnson & Johnson
14.3.6 TOLMAR
14.3.7 Union Chimique Belge
14.3.8 Celgene
14.3.9 Pfizer
14.3.10 Gilead Sciences
14.3.11 Sanofi
14.3.12 Takeda
14.3.13 Bausch&Lomb
14.3.14 Astellas
14.3.15 AMAG Pharmaceuticals
14.3.16 AbbVie
14.3.17 Dr Reddy
